Listed

Endovia Health Sciences, Inc.

EDVANYSECIK 1553788Consumer staplesFiscal year ends Dec 31

Reports and events: 237 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Endovia Health Sciences, Inc., Reports and events
FiledFormWhat it isAccession number
2026-01-2710:04 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001731122-26-000130
2026-01-2616:30 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits0001731122-26-000123
2025-12-2216:32 ETS-1Registration statement0001731122-25-001709
2025-12-1816:26 ETS-1Registration statement0001731122-25-001694
2025-12-1716:10 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001731122-25-001683
2025-12-1016:05 ET8-K1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001731122-25-001659
2025-11-1916:15 ET10-QQuarterly reportPeriod 2025-09-300001731122-25-001571
2025-11-1717:15 ET8-K/A3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits0001731122-25-001560
2025-11-1417:06 ET8-K3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001731122-25-001548
2025-11-0616:20 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results0001731122-25-001493
2025-10-3116:20 ETSCHEDULE 13DOwnership report, active investor0001731122-25-001463
2025-10-3016:50 ET8-K3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits0001731122-25-001454
2025-10-2716:30 ET8-K/A5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001731122-25-001440
2025-10-2716:15 ETSCHEDULE 13DOwnership report, active investor0001731122-25-001438
2025-10-2117:13 ETSCHEDULE 13DOwnership report, active investor0001731122-25-001422
2025-10-2117:09 ETSCHEDULE 13DOwnership report, active investor0001731122-25-001421
2025-10-2116:35 ETSCHEDULE 13DOwnership report, active investor0001731122-25-001419
2025-10-2116:16 ETSCHEDULE 13DOwnership report, active investor0001731122-25-001417
2025-10-1716:16 ET8-K5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001731122-25-001401
2025-10-0617:12 ETDEF 14AProxy statementPeriod 2025-10-060001731122-25-001357
2025-10-0116:30 ET8-K5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001731122-25-001337
2025-09-2516:24 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits0001731122-25-001300
2025-09-0407:05 ET8-K5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001731122-25-001195
2025-08-1416:40 ET10-QQuarterly reportPeriod 2025-06-300001731122-25-001134
2025-08-0716:06 ETDEF 14AProxy statementPeriod 2025-08-070001731122-25-001084
2025-07-3008:46 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001731122-25-001051
2025-07-2913:15 ET8-K3.01 Delisting notice; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001731122-25-001046
2025-07-1117:16 ET10-QQuarterly reportPeriod 2025-03-310001731122-25-000967
2025-07-1117:06 ET10-KAnnual reportPeriod 2024-12-310001731122-25-000964
2025-06-2611:51 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001731122-25-000912
2025-06-2610:31 ET8-K1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001731122-25-000910
2025-06-1316:30 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001731122-25-000876
2025-04-1717:25 ET8-K3.01 Delisting notice; 9.01 Financial statements and exhibits0001731122-25-000584
2025-04-1117:29 ET8-K3.01 Delisting notice; 8.01 Other events; 9.01 Financial statements and exhibits0001731122-25-000569
2025-04-0317:48 ET8-K3.03 Change to security holders’ rights; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws0001731122-25-000508
2025-02-1217:20 ET8-K5.02 Departure or appointment of officers or directors0001731122-25-000211
2025-02-0416:59 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001731122-25-000166
2024-12-0906:12 ETS-1Registration statement0001731122-24-001951
2024-11-1816:16 ET8-K5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001731122-24-001825
2024-11-1517:26 ET10-QQuarterly reportPeriod 2024-09-300001731122-24-001822
2024-10-2216:12 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 2.04 Item not in the standard list; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits0001731122-24-001643
2024-10-1816:06 ETDEF 14AProxy statementPeriod 2024-10-180001731122-24-001618
2024-08-2610:19 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits0001731122-24-001315
2024-08-1416:31 ET10-QQuarterly reportPeriod 2024-06-300001731122-24-001253
2024-08-0617:15 ET8-K5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001731122-24-001205
2024-07-0317:15 ETDEF 14AProxy statementPeriod 2024-07-030001731122-24-001086
2024-06-1817:29 ET8-K3.01 Delisting notice; 8.01 Other events; 9.01 Financial statements and exhibits0001731122-24-000967
2024-05-1517:15 ET10-QQuarterly reportPeriod 2024-03-310001731122-24-000818
2024-05-0717:25 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits0001731122-24-000753
2024-04-2617:19 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001731122-24-000700

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 4, 2026, 06:06 ET. Listed shows no prices and gives no investment advice.